Page 8 - Indian (NIFTY) Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 24, 2024

Discover Indian Pharmaceuticals & Biotech Growth Stocks that are on the NIFTY. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

194 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

INFINIUM

Infinium Pharmachem
₹219.70-2.8%123.9%₹3.0bn/aPE30xn/an/a

538964

Mercury Laboratories
₹875.75-1.6%45.7%₹1.1bn/aPE25.6xn/a0.4%

VALIANTLAB

Valiant Laboratories
₹158.50-0.06%n/a₹6.9bn/aPE26.9xn/an/a

539561

Remedium Lifecare
₹107.95-5.7%101.8%₹10.9bn/aPE20.6xn/an/a

VILINBIO

Vilin Bio Med
₹20.005.3%n/a₹279.0mn/aPE19.1xn/an/a

SMSLIFE

SMS Lifesciences India
₹674.95-8.3%23.7%₹2.0bn/aPE41.7xn/a0.2%

524212

Wanbury
₹158.605.9%230.6%₹5.3bn/aPE22.3xn/an/a

531207

Raymed Labs
₹2.390%17.2%₹10.2mn/aPE-7.8xn/an/a

523620

Phaarmasia
₹39.59-1.0%45.0%₹270.3mn/aPB2.6xn/an/a

VINEETLAB

Vineet Laboratories
₹54.656.0%18.2%₹503.8mn/aPE19xn/a0%

532384

Tyche Industries
₹216.950.1%18.5%₹2.2bn/aPE15.6xn/a0.9%

JFLLIFE

JFL Life Sciences
₹43.009.4%-1.1%₹472.9mn/aPE15.2xn/an/a

SAKAR

Sakar Healthcare
₹354.45-1.9%64.6%₹6.7bn/aPE54.1xn/an/a

524774

NGL Fine-Chem
₹2,711.856.7%87.2%₹16.8bn/aPE44.1xn/a0.06%

VAISHALI

Vaishali Pharma
₹158.90-3.0%10.6%₹1.7bn/aPE28.8xn/an/a

531569

Sanjivani Paranteral
₹185.8010.2%241.4%₹2.2bn/aPE36.8xn/an/a

JAGSNPHARM

Jagsonpal Pharmaceuticals
₹333.353.2%-1.9%₹8.8bn/aPE35.9xn/a1.5%

ACCENTMIC

Accent Microcell
₹268.001.4%n/a₹5.6bn/aPE43.3xn/a0%

540359

Parmax Pharma
₹29.80-5.4%-4.1%₹111.5mn/an/an/an/a

DCAL

Dishman Carbogen Amcis
₹233.406.3%65.3%₹36.6bn/aPS1.4xn/a0%

524414

Norris Medicines
₹12.92-7.6%3.8%₹129.2mn/aPS2.4xn/an/a

526345

Panjon
₹20.005.0%37.9%₹310.0mn/aPE39.2xn/an/a

540937

Medico Remedies
₹46.89-3.3%-43.6%₹3.9bn/aPE55.9xn/an/a

531739

Gennex Laboratories
₹16.27-1.6%172.5%₹3.7bn/aPE34.5xn/an/a
Page 8 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.